- Case Report
- Open Access
Nosocomial valve endocarditis due to corynebacterium striatum: a case report
© Marull and Casares; licensee BioMed Central Ltd. 2008
- Received: 01 September 2008
- Accepted: 12 December 2008
- Published: 12 December 2008
Staphylococcus aureus, Coagulase-negative staphylococci, and Enterococci sp. are the usual pathogens involved in nosocomial bacterial endocarditis. Corynebacterium species isolation in blood specimens is usually considered to be a contaminant. We present an interesting case of native mitral valve endocarditis in a 73 year old African American female that was diagnosed days after she was discharged from our institution. The infection was cleared with medical therapy alone.
- Infective Endocarditis
- Positive Blood Culture
Over the past twenty years, the epidemiological profile of infective endocarditis has been changing.  The number of cases of hospital-acquired endocarditis has been increasing. This entity carries a higher mortality rate compared with community-acquired cases. Indwelling catheters, intravenous lines, intravascular procedures and devices have increased the risk of bacteriemia.  The presentation is not always evident and especial importance should be given to the clinical history in a patient with fever and no evident source of infection. Positive blood cultures for Corynebacterium species, and Corynebacterium striatum in particular, should never be overlooked.
Basic metabolic panel and complete blood cell count
Hepatitis panel non-reactive
Antibiotic resistance profile
> 4 R
> 2 R
> 2 R
> 2 R
Two of the Duke major criteria were met, including the microbiology and echocardiographic findings, making a definitive diagnosis.  There is neither a recognized standard method nor specific MIC breakpoints or guidelines published by NICCS for antimicrobial testing of coryneform bacteria. National Committee for Clinical Laboratory Standards interpretive criteria currently valid for staphylococci, streptococci, or listeria monocytogenes was applied. Chester in 1901 and then Eberson in 1918 described for the first time the Striatum strain, and since then numerous corynebacterium species have been identified and reclassified, in different strains. 
In the 1980s and 1990s CS infections have been disregarded. It was only until recently that Corynebacterium diphtheria was considered to be the only pathogen of the coryneform species. Today, other species, such as C. jeikeium, C. urealiticum, C. amycolatum along with CS, are recognized as emerging hospital pathogens. The pathogenicity in non-diphtheriae corynebacteria species isn't well-known. Neither toxin nor other virulence factors explain the transition from colonization to infection.  Martin et al. isolated identical strains of CS from a leg ulcer and from the bloodstream in a patient with peripheral vascular disease, confirming the entry of the bacterium through the skin to the circulation.  The spectrum of diseases generated by CS is extensive, going from meningitis, keratitis, to arthritis, among others. 
The spread of CS from patient to patient and nosocomial outbreaks have been documented. Leonard et al., Iaria et al., and Brandenbrug described outbreaks caused by a single strain in intensive care unit settings. Leonard et al., described a selective pressure due to prior exposure to antibiotics favoring the overgrowth of CS in immune deficient patients. Brandenbrug et al recovered the strain in the air around infected patients and on the hands of the housestaff. [7–9]. Vancomycin is still the drug of choice for many authors since in vitro resistance has not been showed for this or any other Corynebacterium species. The spread of multidrug resistance strains of CS is concerning, although the mechanisms are not cleared. Ten years ago, CS was still sensitive to beta lactams, fluoroquinolones, carbapenems and linezolid. [10, 11]
In the hospital setting, positive blood cultures for Corynebacterium species, and CS in particular, should never be overlooked. Unlike other hospital-acquired pathogens such as staphylococcal or enterococcal species, that tend to infect patients with a predisposing condition such as a valvulopathy, CS endocarditis can be seen even in patients without prosthetic valves or structural heart disease. More research needs to be conducted to evidence what resistance mechanisms are involving this organism. Nowadays CS is being considered one of the emergent nosocomial agents implicated in endocarditis and serious infections.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Cabell CH, Jollis JG, et al: Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002, 162 (1): 90-4. 10.1001/archinte.162.1.90.View ArticlePubMedGoogle Scholar
- Martin-Davila P, Fortum J, et al: Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest. 2003, 128 (2): 772-9. 10.1378/chest.128.2.772.View ArticleGoogle Scholar
- Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR: Proposed modification to the Duke criteria of infective endocarditis. Clin Infect Dis. 2000, 30: 633-638. 10.1086/313753.View ArticlePubMedGoogle Scholar
- Skerman VBD, McGowan V, Sneath PHA, (editors): Approved Lists of Bacterial Names. Med J Aust. 1980, 2 (1): 3-4.Google Scholar
- Watkins DA, Chaine A, Creger RJ, Jacobs MR, Lazarus HM: Corynebacterium Striatum: a Diphteroid with pathogenic potential. Clin Infect Dis. 1993, 17: 21-5.View ArticlePubMedGoogle Scholar
- Martin MC, Melon O, Celada MM, Alvarez J, Mendez FJ, Vazquez F: Septicaemia due to Corynebacterium striatum: molecular confirmation of entry via the skin. J Med Microbiol. 2003, 52 (Pt 7): 599-602. 10.1099/jmm.0.05102-0.View ArticlePubMedGoogle Scholar
- Leonard RB, Nowowiejski DJ, Warren JJ, Finn DJ, Coyle MB: Molecular evidence of person-to-person transmission of pigmented strain of Corynebacterium striatum in intensive care units. J Clin Microbiol. 1994, 32 (1): 164-9.PubMed CentralPubMedGoogle Scholar
- Iaria C, Stassi G, Costa GB, Biondo C, Gerace E, Noto A, Spinella SG, David A, Cascio A: Outbreak of multi-resistant Corynebacterium striatum infection in an Italian general intensive care unit. J Hosp Infect. 1990, 67 (1): 102-104. 10.1016/j.jhin.2007.07.002.View ArticleGoogle Scholar
- Brandenburg AH, Van Belkum A, Van Pelt C, Bruining HA, Mouton JW, Verbrugh HA: Patient-to-patient spread of a single strain of Corynebacterium striatum causing infections in a surgical intensive care unit. J Clin Microbiol. 1996, 34 (9): 2089-2094.PubMed CentralPubMedGoogle Scholar
- Otsuka Y, Ohkusu K, Kawamura Y, Baba S, Ezaki T, Kimura S: Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in a long-term hospitalized patients with underlying diseases. Diag Microbiol Infect Dis. 2006, 54 (2): 109-14. 10.1016/j.diagmicrobio.2005.08.005.View ArticleGoogle Scholar
- Renom F, Garau M, Rubi M, Ramis F, Galmes A, Sorano JB: Nosocomial outbreak of Corynebacterium striatum Infection in Patients with Chonic Obstructive Pulmonary Disease. J Clin Microbiol. 2007, 45 (6): 2064-7. 10.1128/JCM.00152-07.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.